Home / Services / By Technology / Protein Engineering Services / Custom Protein Production Services
Custom Protein Production

High-Quality Recombinant Protein Production

From gene synthesis to protein purification—accelerate your research with our comprehensive custom protein expression platforms. Multiple expression systems available: E. coli, Mammalian, Insect, and Cell-Free.

Multiple Systems
High Success Rate
Purity >95%
View Specifications

Trusted by leading research and pharmaceutical institutions

MIT
Pfizer
Stanford
Roche
Johns Hopkins
Merck

Why Choose Us

Multiple expression platforms
Comprehensive QC included
Expert technical consultation
Scalable from μg to kg

Gene Optimization

Professional codon optimization

Multiple Systems

E. coli, CHO, HEK293, Insect

Advanced Purification

Multi-step chromatography

Success Rate
High
Service Overview

Complete Gene-to-Protein Solutions

Industry-leading protein expression services tailored to your research needs.

Gene Synthesis & Optimization

Professional codon optimization and gene synthesis to maximize expression efficiency. Our algorithms ensure optimal translation in your chosen expression system.

  • Codon usage optimization
  • GC content balancing
  • mRNA structure minimization

Multiple Expression Platforms

Choose from E. coli, Mammalian (CHO/HEK293), Insect (Baculovirus), or Cell-Free systems. Each optimized for specific protein types and applications.

  • E. coli for rapid production
  • Mammalian for complex PTMs
  • Insect for large proteins

E. coli Expression

Rapid, cost-effective production for simple proteins.

Mammalian Systems

CHO and HEK293 for human-like PTMs.

Insect Cells

Baculovirus system for complex proteins.

Cell-Free Systems

Fast delivery for toxic proteins.

Ready to Accelerate Your Research?

Get expert consultation on the best expression system for your protein.

Technology Platform

Advanced Expression Technologies

Cutting-edge platforms optimized for maximum protein yield and quality.

E. coli Expression

Rapid expression with proven efficiency for bacterial, antigen, and cytokine proteins.

4-6 Weeks Cost-Effective

Mammalian Systems

CHO and HEK293 for human-like post-translational modifications and superior bioactivity.

6-10 Weeks Full PTMs

Baculovirus-Insect

Sf9, Sf21, and Hi-5 cell lines for complex eukaryotic proteins and structural biology.

8-12 Weeks Large Proteins

Cell-Free Expression

Ultra-fast delivery bypassing cellular limitations. Perfect for toxic proteins and screening.

5-7 Days Rapid

Quality Control

SDS-PAGE Purity analysis
SEC-HPLC Aggregate detection
MS Mass spectrometry verification
COA Certificate of Analysis included

Purification Options

Affinity His, Flag, GST, MBP tags
IEX Ion exchange chromatography
SEC Size exclusion polishing
HIC Hydrophobic interaction
Specifications

Service Specifications

Detailed capabilities across all expression platforms.

Parameter E. coli Mammalian (CHO/HEK) Baculovirus-Insect Cell-Free
Production Scale μg to kg μg to kg μg to g μg to mg
Post-Translational Modifications Limited Full human-like Mammalian-like Defined
Glycosylation None Complex N-glycans Simple N-glycans Limited
Disulfide Bonds Periplasmic/specialized strains Yes Yes Yes (controlled)
Cost Efficiency High Medium Medium-High Medium

Purity Guarantee: >95%

All proteins undergo rigorous multi-step purification with SEC-HPLC verification.

Workflow

Streamlined Service Workflow

From project initiation to delivery in simple, transparent steps.

1

Project Consultation

Discuss requirements and select optimal expression system

2

Gene Synthesis

Codon optimization and gene construction

3

Expression Testing

Pilot expression and condition optimization

4

Purification

Multi-step chromatography purification

5

QC & Delivery

Quality analysis and protein shipment

Applications

Wide Range of Applications

Solutions for research, therapeutic, and industrial needs.

Research Applications

Comprehensive solutions for academic and industrial research projects requiring recombinant proteins.

  • Structural biology studies (X-ray, Cryo-EM)
  • Functional assays and binding studies
  • Antibody generation and validation
  • Enzyme characterization and optimization
10K+
Projects Delivered

Therapeutic Development

GMP-ready production for preclinical and clinical development of therapeutic proteins.

  • Antibody and Fc fusion proteins
  • Cytokines and growth factors
  • Vaccine antigens and virus-like particles
  • Biosimilar development support
GMP
Manufacturing Ready

Diagnostics

High-purity proteins for diagnostic reagent development and quality control.

  • ELISA standards and controls
  • Immunohistochemistry reagents
  • Lateral flow assay components
  • Reference standards for QC
>95%
Purity Guaranteed
Testimonials

What Our Clients Say

Trusted by researchers worldwide for quality and reliability.

"Their mammalian expression system delivered exceptional results for our membrane protein project. The protein was properly folded and functional for our Cryo-EM studies."

R
Principal Scientist
Biotechnology Company

"We've been using their E. coli service for over 3 years. Consistent quality, excellent technical support, and they always meet their timelines."

P
Research Director
Academic Research Institution

"The cell-free expression option saved us weeks on our toxic protein project. Fast, efficient, and the purity exceeded our expectations."

L
Lead Researcher
Pharmaceutical Company
Scientific Literature

Scientific Foundation

Our platform is backed by peer-reviewed research.

85 Citations

A concise guide to choosing suitable gene expression systems for recombinant protein production

Schutz A, Bernhard F, Berrow N, Buyel JF, Ferreira-da-Silva F, Haustraete J, et al. STAR Protocols. 2023.

Comprehensive guide covering E. coli, yeast, mammalian, and insect expression systems for recombinant protein production.

View DOI
28 Citations

High-yield vesicle-packaged recombinant protein production from E. coli

Eastwood TA, Baker K, Streather BR, Allen N, Wang L, Botchway SW, et al. Cell Reports Methods. 2023.

Innovative system for producing recombinant proteins as membrane-bound vesicles in E. coli.

View DOI
156 Citations

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity

Zhang ZX, Nong FT, Wang YZ, Yan CX, Gu Y, Song P, Sun XM. Frontiers in Bioengineering and Biotechnology. 2022.

Optimization strategies for high-level recombinant protein production in E. coli.

View DOI
42 Citations

Protein production from HEK293 cell line-derived stable pools with high protein quality and quantity to support discovery research

Sun H, Wang SY, Lu M, Tinberg CE, Alba BM. PLoS ONE. 2023.

Robust method for protein expression using HEK293-derived stable pools for discovery research.

View DOI
38 Citations

Cell-Free PURE System: Evolution and Achievements

Cui Y, Chen XJ, Wang Z, Lu Y. Biodesign Research. 2022.

Comprehensive review of PURE system applications in synthetic biology and protein production.

View DOI
FAQ

Frequently Asked Questions

Find answers to common questions about our protein production services.

Which expression system should I choose for my protein?
The choice depends on your protein's characteristics and intended application. E. coli is best for simple proteins without complex PTMs, rapid turnaround needed, or budget constraints. Mammalian systems are required for proteins needing human-like glycosylation, antibodies, or maximum bioactivity. Insect cells are ideal for complex eukaryotic proteins, large proteins, or structural biology studies. Cell-Free systems are perfect for toxic proteins, rapid screening, or incorporating non-natural amino acids.
What information do you need to start a project?
We typically need: protein sequence (amino acid sequence or gene sequence), UniProt or NCBI accession number (if available), target expression system preference, required purity level and quantity, downstream application (for QC optimization), and timeline requirements. If you don't have a sequence, we can design optimized gene sequences based on protein function or homolog information.
What purification methods are available?
We offer comprehensive purification options including affinity chromatography (His-tag, Flag-tag, Fc-tag, GST, MBP, SUMO), ion exchange (anion and cation exchange), size exclusion (gel filtration), hydrophobic interaction chromatography, and tag removal using proteases (TEV, SUMO protease, thrombin). Standard service includes affinity plus optional orthogonal polishing steps.
What quality control data is provided?
All projects include comprehensive QC: SDS-PAGE analysis (reducing and non-reducing), protein concentration determination (A280), SEC-HPLC purity analysis, and mass spectrometry verification (upon request). Optional add-ons include endotoxin testing (LAL assay), bioactivity assays, thermal stability analysis, and binding assays (SPR, BLI).
What are the typical yields for different systems?
Yields vary by expression system and protein. E. coli typically produces 1-50 mg/L (soluble). Mammalian (CHO) produces 0.5-5 g/L for antibodies, 10-500 mg/L for other proteins. Mammalian (HEK293) produces 0.1-1 g/L transient, higher for stable pools. Insect cells produce 1-50 mg/L depending on protein complexity. Cell-Free systems produce 0.1-5 mg/mL reaction (highly concentrated).
Can you handle difficult-to-express proteins?
Absolutely. We specialize in challenging proteins including membrane proteins (specialized vectors and detergent screening), multi-subunit complexes (co-expression strategies), proteins with multiple disulfide bonds (optimized folding conditions), toxic proteins (cell-free system or specialized bacterial strains), and large proteins over 150 kDa (insect and mammalian systems).
Do you offer scalable production for large quantities?
Yes, we support scales from micrograms to kilograms. Pilot scale provides 10-100 mg production for initial studies. Pre-clinical scale offers 100 mg to 1 g for formulation development. Industrial scale delivers 1 g to kg range with GMP-ready facilities. Our facilities include bioreactors ranging from 2L to 1500L capacity for seamless scale-up.
What mammalian cell lines do you support?
We offer multiple mammalian expression platforms: CHO-K1 (industry standard for therapeutic proteins), CHO-DG44 (DHFR-based selection for high-yield stable pools), HEK293 (suspension) for rapid transient expression, HEK293F (high-density suspension culture optimized), and BHK-21 for specific viral applications. Each platform can be configured for transient transfection or stable cell line generation.

Ready to Start Your Project?

Get a customized quote for your Custom Protein Production Services project. Our experts will respond within 24 hours.

No obligation
24h response
Expert consultation